Literature DB >> 3047412

AIDS: the role of imaging modalities and infection control policies.

J Moore-Stovall.   

Abstract

The availability of imaging modalities, such as the chest radiograph, gallium scan, double-contrast barium enema, computed tomography, and nuclear magnetic resonance, are very helpful in the diagnosis, treatment, and follow-up evaluation of patients with acquired immunodeficiency syndrome (AIDS). Because this syndrome causes irreversible destruction of the immune system, patients are susceptible to a multitude of opportunistic infections and malignancies. Health care professionals and the general public would be less fearful and apprehensive of AIDS victims if properly informed about the communicability of this syndrome.

Entities:  

Mesh:

Year:  1988        PMID: 3047412      PMCID: PMC2625765     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  5 in total

1.  Revision of HIV classification codes.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1988-01-01       Impact factor: 17.586

2.  Approval of zidovudine (AZT) for acquired immunodeficiency syndrome. A challenge to the medical and pharmaceutical communities.

Authors:  I Brook
Journal:  JAMA       Date:  1987-09-18       Impact factor: 56.272

Review 3.  Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report.

Authors:  R Yarchoan; S Broder
Journal:  N Engl J Med       Date:  1987-02-26       Impact factor: 91.245

4.  The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

Authors:  D D Richman; M A Fischl; M H Grieco; M S Gottlieb; P A Volberding; O L Laskin; J M Leedom; J E Groopman; D Mildvan; M S Hirsch
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

5.  AIDS: definition and guidelines for the health professional.

Authors:  M J Healey
Journal:  Radiol Technol       Date:  1986 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.